0001104659-20-062414.txt : 20200515 0001104659-20-062414.hdr.sgml : 20200515 20200515135820 ACCESSION NUMBER: 0001104659-20-062414 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200515 FILED AS OF DATE: 20200515 DATE AS OF CHANGE: 20200515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Andrade Robert CENTRAL INDEX KEY: 0001468308 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32295 FILM NUMBER: 20883626 MAIL ADDRESS: STREET 1: C/O ADHEREX TECHNOLOGIES INC. STREET 2: 4620 CREEKSTONE DRIVE, SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FENNEC PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001211583 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: PO BOX 13628 STREET 2: 68 TW ALEXANDER DRIVE CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: (919) 636-4530 MAIL ADDRESS: STREET 1: PO BOX 13628 STREET 2: 68 TW ALEXANDER DRIVE CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 FORMER COMPANY: FORMER CONFORMED NAME: FENNEC PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20140903 FORMER COMPANY: FORMER CONFORMED NAME: ADHEREX TECHNOLOGIES INC DATE OF NAME CHANGE: 20021223 4 1 tm2019938d3_4.xml OWNERSHIP DOCUMENT X0306 4 2020-05-15 0 0001211583 FENNEC PHARMACEUTICALS INC. FENC 0001468308 Andrade Robert 68 TW ALEXANDER DRIVE, PO BOX 13628 DURHAM NC 27709 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 6.93 2020-05-15 4 A 0 125000 0 A 2030-05-15 Common Shares 125000 125000 D On May 15, 2020, Robert Andrade was granted an incentive stock option to purchase 125,000 shares of the Issuer's common shares pursuant to the Issuer's Amended and Restated Stock Option Plan. 1/3 of the shares subject to this option shall vest immediately and may be exercised as of May 15, 2021 (the "Vesting Commencement Date"). 1/24 of the shares subject to this option shall vest immediately and may be exercised as of the last day of each month following the Vesting Commencement Date. As of May 15, 2023 and thereafter, 100% of the total number of shares subject to this option shall be vested. /s/ Robert Andrade 2020-05-15